1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. ARBUTUS BIOPHARMA CORP
Arbutus Biopharma Corp XNAS: ABUS
4.14 -0.06 (-1.43%)
1.3M

XNAS 21 Jan, 2026 4:30 PM (EST)

Watchlist

Portfolio

Alert

Arbutus Biopharma Corp - ABUS - stock price prediction, stock price target, analyst ratings from 3 analysts

Arbutus Biopharma Corp has a share price target of US$ 6, revenue growth forecast of 127.9%, and profit growth estimate of 47.5% for FY25, based on top 3 analyst calls.